nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—RYR1—larynx—muscle cancer	0.0684	0.121	CbGeAlD
Suramin—F2—hindlimb—muscle cancer	0.0304	0.0536	CbGeAlD
Suramin—F2—appendage—muscle cancer	0.0261	0.046	CbGeAlD
Suramin—P2RY2—renal system—muscle cancer	0.0242	0.0427	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—PAX3—muscle cancer	0.0232	0.0557	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—TFE3—muscle cancer	0.0214	0.0514	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—MYOD1—muscle cancer	0.0195	0.0468	CbGpPWpGaD
Suramin—PLA2G4A—Raltitrexed—Methotrexate—muscle cancer	0.0174	1	CbGdCrCtD
Suramin—FSHR—FSH signaling pathway—FOXO1—muscle cancer	0.0164	0.0394	CbGpPWpGaD
Suramin—P2RY2—head—muscle cancer	0.0162	0.0286	CbGeAlD
Suramin—SIRT5—renal system—muscle cancer	0.015	0.0264	CbGeAlD
Suramin—FSHR—testis—muscle cancer	0.0147	0.026	CbGeAlD
Suramin—SIRT1—E2F transcription factor network—TP73—muscle cancer	0.0145	0.0347	CbGpPWpGaD
Suramin—P2RX4—renal system—muscle cancer	0.0141	0.025	CbGeAlD
Suramin—SIRT1—p73 transcription factor network—TP73—muscle cancer	0.0136	0.0326	CbGpPWpGaD
Suramin—SIRT5—cardiac atrium—muscle cancer	0.0134	0.0236	CbGeAlD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—FOXO4—muscle cancer	0.0132	0.0318	CbGpPWpGaD
Suramin—SIRT1—Regulation of retinoblastoma protein—MYOD1—muscle cancer	0.0128	0.0307	CbGpPWpGaD
Suramin—P2RX4—cardiac atrium—muscle cancer	0.0127	0.0224	CbGeAlD
Suramin—SIRT1—renal system—muscle cancer	0.0124	0.0219	CbGeAlD
Suramin—ARSA—renal system—muscle cancer	0.0122	0.0216	CbGeAlD
Suramin—RYR1—smooth muscle tissue—muscle cancer	0.0119	0.021	CbGeAlD
Suramin—SIRT5—tendon—muscle cancer	0.0117	0.0206	CbGeAlD
Suramin—SIRT1—p73 transcription factor network—TP63—muscle cancer	0.0117	0.028	CbGpPWpGaD
Suramin—SIRT1—cardiac atrium—muscle cancer	0.0111	0.0196	CbGeAlD
Suramin—P2RX4—tendon—muscle cancer	0.011	0.0195	CbGeAlD
Suramin—SIRT1—FoxO family signaling—FOXO4—muscle cancer	0.011	0.0265	CbGpPWpGaD
Suramin—SIRT5—vagina—muscle cancer	0.0108	0.0191	CbGeAlD
Suramin—P2RX4—bone marrow—muscle cancer	0.0107	0.0189	CbGeAlD
Suramin—SIRT1—p73 transcription factor network—WT1—muscle cancer	0.0103	0.0247	CbGpPWpGaD
Suramin—P2RX4—vagina—muscle cancer	0.0102	0.0181	CbGeAlD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.0102	0.0244	CbGpPWpGaD
Suramin—SIRT5—head—muscle cancer	0.01	0.0177	CbGeAlD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—FOXO1—muscle cancer	0.00977	0.0235	CbGpPWpGaD
Suramin—SIRT1—tendon—muscle cancer	0.00967	0.0171	CbGeAlD
Suramin—SIRT5—testis—muscle cancer	0.00967	0.0171	CbGeAlD
Suramin—P2RX4—head—muscle cancer	0.00946	0.0167	CbGeAlD
Suramin—SIRT1—bone marrow—muscle cancer	0.00937	0.0165	CbGeAlD
Suramin—P2RX4—testis—muscle cancer	0.00914	0.0161	CbGeAlD
Suramin—PLA2G2A—smooth muscle tissue—muscle cancer	0.00901	0.0159	CbGeAlD
Suramin—SIRT1—vagina—muscle cancer	0.00898	0.0158	CbGeAlD
Suramin—RYR1—tendon—muscle cancer	0.00894	0.0158	CbGeAlD
Suramin—ARSA—vagina—muscle cancer	0.00887	0.0157	CbGeAlD
Suramin—PLA2G2A—renal system—muscle cancer	0.00868	0.0153	CbGeAlD
Suramin—RYR1—vagina—muscle cancer	0.00829	0.0146	CbGeAlD
Suramin—SIRT1—head—muscle cancer	0.00829	0.0146	CbGeAlD
Suramin—FSHR—GPCRs, Other—CNR1—muscle cancer	0.00824	0.0198	CbGpPWpGaD
Suramin—ARSA—head—muscle cancer	0.00819	0.0145	CbGeAlD
Suramin—SIRT1—FoxO family signaling—FOXO1—muscle cancer	0.00814	0.0196	CbGpPWpGaD
Suramin—SIRT1—testis—muscle cancer	0.00801	0.0141	CbGeAlD
Suramin—ARSA—testis—muscle cancer	0.00791	0.014	CbGeAlD
Suramin—PLA2G2A—cardiac atrium—muscle cancer	0.00777	0.0137	CbGeAlD
Suramin—RYR1—head—muscle cancer	0.00766	0.0135	CbGeAlD
Suramin—SIRT1—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.00764	0.0184	CbGpPWpGaD
Suramin—RYR1—testis—muscle cancer	0.0074	0.0131	CbGeAlD
Suramin—ARSA—Metabolism of proteins—TIMM10—muscle cancer	0.00728	0.0175	CbGpPWpGaD
Suramin—PLA2G2A—tendon—muscle cancer	0.00677	0.012	CbGeAlD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00662	0.0159	CbGpPWpGaD
Suramin—F2—renal system—muscle cancer	0.00655	0.0116	CbGeAlD
Suramin—F2—Regulation of IGF Activity by IGFBP—IGF2—muscle cancer	0.00644	0.0155	CbGpPWpGaD
Suramin—PLA2G4A—smooth muscle tissue—muscle cancer	0.00627	0.0111	CbGeAlD
Suramin—PLA2G4A—renal system—muscle cancer	0.00603	0.0106	CbGeAlD
Suramin—PLA2G2A—Eicosanoid Synthesis—PTGS2—muscle cancer	0.00598	0.0144	CbGpPWpGaD
Suramin—PLA2G2A—head—muscle cancer	0.00581	0.0102	CbGeAlD
Suramin—PLA2G2A—testis—muscle cancer	0.00561	0.0099	CbGeAlD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00507	0.0122	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—FOXO1—muscle cancer	0.00505	0.0121	CbGpPWpGaD
Suramin—SIRT1—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.00497	0.0119	CbGpPWpGaD
Suramin—F2—bone marrow—muscle cancer	0.00495	0.00874	CbGeAlD
Suramin—PLA2G4A—tendon—muscle cancer	0.00471	0.00831	CbGeAlD
Suramin—SIRT1—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.00458	0.011	CbGpPWpGaD
Suramin—PLA2G4A—bone marrow—muscle cancer	0.00456	0.00805	CbGeAlD
Suramin—PLA2G2A—Glypican 1 network—VEGFA—muscle cancer	0.00442	0.0106	CbGpPWpGaD
Suramin—F2—head—muscle cancer	0.00438	0.00774	CbGeAlD
Suramin—PLA2G4A—vagina—muscle cancer	0.00437	0.00771	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—CDKN2A—muscle cancer	0.00397	0.00953	CbGpPWpGaD
Suramin—PLA2G4A—testis—muscle cancer	0.0039	0.00688	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—MDM2—muscle cancer	0.00385	0.00925	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—ANGPT2—muscle cancer	0.00383	0.00921	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00371	0.00892	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00371	0.00891	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—CDKN2A—muscle cancer	0.00366	0.00879	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00358	0.00861	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—TP53—muscle cancer	0.00336	0.00808	CbGpPWpGaD
Suramin—SIRT1—p73 transcription factor network—MDM2—muscle cancer	0.00333	0.00801	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.00331	0.00795	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—HMGA1—muscle cancer	0.00319	0.00767	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00318	0.00763	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00307	0.00737	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—MDM2—muscle cancer	0.00303	0.00728	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.00296	0.00712	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—FOXO4—muscle cancer	0.00294	0.00706	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—PTCH1—muscle cancer	0.00287	0.00689	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—PTCH1—muscle cancer	0.00277	0.00665	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CNR1—muscle cancer	0.00242	0.00581	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TIMM10—muscle cancer	0.00242	0.00581	CbGpPWpGaD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.00236	0.00567	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CNR1—muscle cancer	0.00234	0.00562	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00232	0.00559	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KIDINS220—muscle cancer	0.00221	0.0053	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—FOXO1—muscle cancer	0.00217	0.00522	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KIDINS220—muscle cancer	0.00213	0.00512	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	0.00209	0.00501	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.00198	0.00477	CbGpPWpGaD
Suramin—ARSA—Metabolism—FH—muscle cancer	0.00183	0.0044	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00172	0.00413	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—PTGS2—muscle cancer	0.00167	0.00402	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.00164	0.00395	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.00158	0.00381	CbGpPWpGaD
Suramin—PLA2G4A—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00157	0.00377	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.00151	0.00362	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.0015	0.0036	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PTCH1—muscle cancer	0.00147	0.00353	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PTCH1—muscle cancer	0.00142	0.00341	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CNR1—muscle cancer	0.00137	0.00329	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CNR1—muscle cancer	0.00132	0.00317	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CDKN2A—muscle cancer	0.00131	0.00314	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—MDM2—muscle cancer	0.00127	0.00305	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00126	0.00302	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.00125	0.003	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CNR1—muscle cancer	0.00124	0.00298	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	0.00124	0.00298	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CNR1—muscle cancer	0.0012	0.00288	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGF2—muscle cancer	0.0012	0.00288	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MED12—muscle cancer	0.00119	0.00287	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—FH—muscle cancer	0.00118	0.00284	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.00114	0.00274	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—PTGS2—muscle cancer	0.00109	0.00262	CbGpPWpGaD
Suramin—F2—Hemostasis—ANGPT2—muscle cancer	0.00104	0.0025	CbGpPWpGaD
Suramin—ARSA—Metabolism—MED12—muscle cancer	0.00103	0.00249	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—muscle cancer	0.000996	0.00239	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.00098	0.00236	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—VEGFA—muscle cancer	0.000964	0.00232	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ANGPT2—muscle cancer	0.000951	0.00228	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—muscle cancer	0.000943	0.00227	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000943	0.00227	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000908	0.00218	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—muscle cancer	0.000906	0.00218	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000897	0.00216	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTCH1—muscle cancer	0.000869	0.00209	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTCH1—muscle cancer	0.000839	0.00202	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTCH1—muscle cancer	0.000819	0.00197	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—muscle cancer	0.000817	0.00196	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FOXO4—muscle cancer	0.000747	0.0018	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000738	0.00177	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CNR1—muscle cancer	0.000733	0.00176	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—muscle cancer	0.000728	0.00175	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FOXO4—muscle cancer	0.000722	0.00173	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CNR1—muscle cancer	0.000708	0.0017	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000706	0.0017	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CNR1—muscle cancer	0.000691	0.00166	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MED12—muscle cancer	0.000667	0.0016	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KIDINS220—muscle cancer	0.000631	0.00152	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—muscle cancer	0.000608	0.00146	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF2—muscle cancer	0.0006	0.00144	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF2—muscle cancer	0.000579	0.00139	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KIDINS220—muscle cancer	0.000577	0.00139	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000557	0.00134	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—FH—muscle cancer	0.000556	0.00134	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FOXO1—muscle cancer	0.000552	0.00133	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000536	0.00129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FOXO1—muscle cancer	0.000533	0.00128	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF2—muscle cancer	0.000505	0.00121	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000475	0.00114	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF2—muscle cancer	0.000462	0.00111	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000423	0.00102	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KIT—muscle cancer	0.00042	0.00101	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTCH1—muscle cancer	0.00042	0.00101	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000411	0.000988	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KIT—muscle cancer	0.000406	0.000976	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF2—muscle cancer	0.000398	0.000955	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CNR1—muscle cancer	0.000391	0.000939	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTCH1—muscle cancer	0.000384	0.000924	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000376	0.000904	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CNR1—muscle cancer	0.000355	0.000853	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MDM2—muscle cancer	0.000331	0.000796	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—muscle cancer	0.000329	0.00079	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CNR1—muscle cancer	0.000324	0.00078	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MDM2—muscle cancer	0.00032	0.000769	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000319	0.000767	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MED12—muscle cancer	0.000314	0.000755	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—muscle cancer	0.000286	0.000689	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—muscle cancer	0.000251	0.000604	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH1—muscle cancer	0.000248	0.000597	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—muscle cancer	0.000243	0.000584	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH1—muscle cancer	0.000227	0.000546	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000224	0.000538	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FOXO4—muscle cancer	0.000213	0.000513	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—muscle cancer	0.000212	0.000509	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—muscle cancer	0.000212	0.000509	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR1—muscle cancer	0.00021	0.000504	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FOXO4—muscle cancer	0.000195	0.000469	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—muscle cancer	0.000194	0.000466	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR1—muscle cancer	0.000192	0.000461	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—muscle cancer	0.00019	0.000457	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—muscle cancer	0.000183	0.000441	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF2—muscle cancer	0.000171	0.000412	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—muscle cancer	0.00016	0.000385	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FOXO1—muscle cancer	0.000158	0.000379	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF2—muscle cancer	0.000157	0.000377	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—muscle cancer	0.000146	0.000352	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FOXO1—muscle cancer	0.000144	0.000347	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KIT—muscle cancer	0.00012	0.000289	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KIT—muscle cancer	0.00011	0.000264	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—muscle cancer	9.98e-05	0.00024	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MDM2—muscle cancer	9.46e-05	0.000227	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MDM2—muscle cancer	8.65e-05	0.000208	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—muscle cancer	7.18e-05	0.000173	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—muscle cancer	6.57e-05	0.000158	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—muscle cancer	5.43e-05	0.00013	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—muscle cancer	4.97e-05	0.000119	CbGpPWpGaD
